Neurodevelopmental outcomes in children and adults associated with antenatal corticosteroid exposure: a narrative

Luojia Li1, Joanne M Said1,2, Klea Atallah1

  • 1Department of Obstetrics, Gynaecology and Newborn Health, The University of Melbourne, Melbourne, Australia.

PubMed

Insights

Antenatal corticosteroids may impact long-term neurodevelopment in children and adults, with studies showing mixed results. Further research is needed to clarify the benefits and risks of this fetal lung maturation treatment.

Area of Science:

  • Perinatology
  • Neurodevelopmental Pediatrics
  • Pharmacology

Background:

  • Preterm birth presents significant risks for newborns, necessitating interventions like antenatal corticosteroids for fetal lung maturation.
  • Concerns exist regarding potential long-term neurodevelopmental harms in individuals exposed to antenatal corticosteroids.
  • Existing literature presents a complex and inconclusive picture of these associations.

Purpose of the Study:

  • To conduct a narrative review of published literature on the associations between antenatal corticosteroid exposure and neurodevelopmental outcomes in children and adults.
  • To synthesize evidence on motor, cognitive, neurosensory, and behavioral impairments following antenatal corticosteroid exposure.

Main Methods:

  • Systematic search of academic databases (PubMed, Ovid MEDLINE, Ovid Embase) for articles published between 1995 and 2024.
  • Inclusion criteria focused on maternal corticosteroid administration and childhood/adulthood neurodevelopmental outcomes.
  • Analysis of 15 studies involving over 8.3 million participants, with follow-up assessments ranging from 2 to 31 years.

Main Results:

  • Most studies reported either an increased likelihood or no association between antenatal corticosteroid exposure and adverse neurodevelopment.
  • Some studies indicated potential benefits, such as reduced risk of cerebral palsy and cognitive impairments.
  • Findings were complex, with significant variability across studies and outcomes.

Conclusions:

  • The evidence regarding long-term neurodevelopmental outcomes following antenatal corticosteroid exposure is complex and inconclusive.
  • Further research is essential to elucidate the precise benefits and risks in diverse clinical scenarios.
  • Understanding these associations is crucial for optimizing antenatal care strategies.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.5K
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
717
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.8K
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
2.8K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
919